WallStSmart

High Tide Inc (HITI)vsHong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

High Tide Inc generates 3001% more annual revenue ($629.85M vs $20.31M). HKPD leads profitability with a -0.1% profit margin vs -7.4%. HKPD earns a higher WallStSmart Score of 36/100 (F).

HITI

Avoid

30

out of 100

Grade: F

Growth: 6.0Profit: 3.5Value: 5.0Quality: 4.5
Piotroski: 1/9Altman Z: 0.68

HKPD

Hold

36

out of 100

Grade: F

Growth: 7.3Profit: 2.5Value: 5.0Quality: 5.0

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HITI1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
25.2%8/10

Revenue surging 25.2% year-over-year

HKPD2 strengths · Avg: 10.0/10
Price/BookValuation
1.5x10/10

Reasonable price relative to book value

EPS GrowthGrowth
130.2%10/10

Earnings expanding 130.2% YoY

Areas to Watch

HITI4 concerns · Avg: 3.0/10
Market CapQuality
$196.76M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
2.3%3/10

Operating margin of 2.3%

Debt/EquityHealth
1.713/10

Elevated debt levels

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

HKPD4 concerns · Avg: 2.3/10
Market CapQuality
$6.99M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-0.6%2/10

ROE of -0.6% — below average capital efficiency

Revenue GrowthGrowth
-4.7%2/10

Revenue declined 4.7%

Free Cash FlowQuality
$-106,3932/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : HITI

The strongest argument for HITI centers on Revenue Growth. Revenue growth of 25.2% demonstrates continued momentum.

Bull Case : HKPD

The strongest argument for HKPD centers on Price/Book, EPS Growth.

Bear Case : HITI

The primary concerns for HITI are Market Cap, Operating Margin, Debt/Equity. Debt-to-equity of 1.71 is elevated, increasing financial risk.

Bear Case : HKPD

The primary concerns for HKPD are Market Cap, Return on Equity, Revenue Growth.

Key Dynamics to Monitor

HITI profiles as a growth stock while HKPD is a turnaround play — different risk/reward profiles.

HITI is growing revenue faster at 25.2% — sustainability is the question.

HITI generates stronger free cash flow (4M), providing more financial flexibility.

Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HKPD scores higher overall (36/100 vs 30/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

High Tide Inc

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

High Tide Inc. is a vertically integrated company in the cannabis market in Canada, the United States and internationally. The company is headquartered in Calgary, Canada.

Visit Website →

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Hong Kong Pharma Digital Technology Holdings Limited is a pioneering company at the intersection of biotechnology and digital healthcare, focusing on the integration of cutting-edge technology with pharmaceutical services to enhance patient outcomes and streamline healthcare delivery. Leveraging advanced digital solutions and data analytics, the company optimizes drug development processes and improves operational efficiencies, positioning itself as a critical player in the evolving healthcare landscape. With a strong commitment to health technology advancement and the cultivation of strategic alliances, Hong Kong Pharma is poised to meet the demands of both domestic and global markets while driving innovation across its pharmaceutical service offerings.

Want to dig deeper into these stocks?